THOMAS CONNER: Open Payments
NPI 1780619023 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$339 in 18 payments from 12 companies in 2025. Trend: 2023 $675 · 2024 $623 · 2025 $339
Food & beverage: $339
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $77 |
| Astellas Pharma US Inc | 2 | $39 |
| PFIZER INC. | 2 | $39 |
| Medtronic, Inc. | 2 | $38 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| Abbott Laboratories | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Sonex Health, Inc. | 1 | $17 |
| Seqirus USA Inc | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
Products named: VRAYLAR, Veozah, Auvelity, QULIPTA, INTELLIS ADAPTIVESTIM, FREESTYLE LIBRE 3, PREVNAR 20, INSPIRE.
Industry payments across UT — which companies pay providers there.
